Therapeutic perspectives of hiv-associated chemokine receptor (ccr5 and cxcr4) antagonists in carcinomas

HIGHLIGHTS

  • who: Wilfredo Alejandro Gonzu00e1lez-Arriagada and collaborators from the Facultad de Odontologu00eda, Universidad de Los Andes, Campinas, Piracicaba, SP, Brazil have published the research: Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas, in the Journal: (JOURNAL) of 14/Oct/2022
  • what: In this context, the authors aim to conduct a scoping review of the literature to describe the results of promising CRA therapies for carcinomas to identify the drugs to be used in the future. The present review describes the current therapeutical perspectives of HIVrCR, CCR5, and CXCR4 antagonist drugs . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?